By Siddhi Mahatole and Mariam Sunny (Reuters) -Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron (NASDAQ:REGN) Pharmaceuticals’ offer for the DNA-testing company in a bankruptcy auction. Last month, Regeneron agreed to buy the firm for $256 million, topping a $146 million bid from Wojcicki and the non-profit TTAM Research I ...
By Anna Tong, Kenrick Cai and Krystal Hu SAN FRANCISCO (Reuters) -Alphabet’s Google (NASDAQ:GOOGL), the largest customer of Scale AI, plans to cut ties with Scale after news broke that rival Meta (NASDAQ:META) is taking a 49% stake in the AI data-labeling startup, five sources familiar with the matter told Reuters. Google had planned to pay Scale AI about $200 million this year for the human-l ...
By Puyaan Singh (Reuters) -KalVista Pharmaceuticals’ said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a type of hereditary swelling disorder due to heavy workload and limited resources. The FDA indicated that it now expects to deliver a decision within four weeks, KalVista said. The original target action date for the decision on the medication, ...
WASHINGTON (Reuters) -Nippon Steel’s $14.9 billion bid for U.S. Steel poses a national security risk, but those concerns can be mitigated if the companies fulfill certain conditions laid out by the Trump administration, U.S. President Donald Trump said in a executive order on Friday. "I additionally find that the threatened impairment to the national security of the United States arising as a re ...